To further elucidate the molecular mechanisms of combination strategy-triggered autophagic cell death, we explored whether the treatment could induce lung cancer cell autophagy through the inhibition of PI3K-AKT-mTOR signaling. The gene discussed is AKT1; the disease is lung carcinoma.